ASAT

Login
  • About ASAT
  • About Autism
  • Intervention
  • Conferences
  • Resources
  • Media Watch
  • Text size:
  • S
  • M
  • L
  • XL
  • High Contrast:
  • S
  • M
  • L
  • XL
Intervention Autism Treatment... Summaries of Sci... Vitamin and Supp...
  • Intervention
  • Autism treatments: Descriptions and research summaries
  • Video Examples
  • Description of Service Providers
  • Making Sense of Autism Treatments: Weighing the evidence
  • Recommendations of expert panels & government task forces

Vitamin and Supplement Therapy

Description: Administration of a vitamin, mineral, or nutritional supplement in the form of a pill, powder, liquid, cream, bath, or injection.

Examples: Vitamin A; Vitamin B6; Vitamin B12; Vitamin C; Vitamin D; Magnesium; Dimethylglycine (DMG); Calcium; Omega 3 Fatty Acids

Research Summary: Three small but well-designed studies indicated that B6 with magnesium is ineffective in changing behavior (Findling et al., 1997; Kuriyama et al., 2002; Tolber, Haigler, Waits, & Dennis, 1993), but further study may be warranted (Nye & Brice, 2005).

No well-designed studies have evaluated other vitamin and supplement therapies for individuals with autism spectrum disorders.

Recommendations: Researchers may wish to conduct large studies with strong scientific designs to obtain more conclusive evidence on whether B6 with magnesium is effective or not. Other vitamin therapies also may warrant further study. Professionals should present vitamin therapy as unsupported by research and encourage families who are considering this intervention to evaluate its effects and side-effects carefully.

Selected References:

Selected scientific studies:

  • Findling, R. L., Maxwell, K., Scotese-Wojtila, L., Huang, J., Yamashita, T., & Wiznitzer, M. (1997). High-dose pyridoxine and magnesium administration in children with autistic disorder: An absence of salutary effects in a double-blind, placebo-controlled study. Journal of Autism and Developmental Disorders, 27, 467-478.
  • Kuriyama, S., Kamiyama, M., Watanabe, M., Tamahashi, S., Muraguchi, I., Watanabe, T., et al. (2002). Pyridoxine treatment in a subgroup of children with pervasive developmental disorders. Developmental Medicine & Child Neurology, 44, 284-246.
  • Tolbert, L., Haigler, T., Waits, M. M., & Dennis, T. (1993). Brief report: Lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium. Journal of Autism and Developmental Disabilities, 23, 193-199.

Systematic reviews of scientific studies:

  • Nye, C., & Brice, A. (2005). Combined vitamin B6-magnesium treatment in autism spectrum disorder. The Cochrane Database of Systematic Reviews, 4.
Winter Newsletter
Now Available
Newsletter
Sign up now

Site Map • Privacy Policy • Contact Us

P.O. Box 188, Crosswicks, NJ 08515-0188 • info@asatonline.org

© Association for Science in Autism Treatment. This article is for personal use only. This article may not be republished or reprinted without advance permission from ASAT. For reprint permission please contact reprints@asatonline.org